Cacciante, Francesco
Gennaro, Mariangela
Sagona, Giulia
Mazziotti, Raffaele
Lupori, Leonardo
Cerri, Elisa
Putignano, Elena
Butt, Mark
Do, Minh-Ha T.
McKew, John C.
Alessandrì, Maria Grazia
Battini, Roberta
Cioni, Giovanni
Pizzorusso, Tommaso
Baroncelli, Laura
Funding for this research was provided by:
Lumos Pharma (LUM-001)
Italian Ministry of Health (GR-2017-02364378)
Article History
Received: 20 July 2020
Accepted: 25 September 2020
First Online: 27 October 2020
Competing interests
: The authors report no competing interests, except for funding obtained to carry out the research. M. T. Do and J. C. McKew are employees of Lumos Pharma. Cyclocreatine used in this study was being developed by Lumos Pharma.